Selected research
Industry Research
Joint Pain Injections Industry Research Report 2026
Market perspective
The global Joint Pain Injections market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Joint Pain Injections is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Joint Pain Injections is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Joint Pain Injections include Chugai Pharmaceutical, Sanofi, Pfizer, Ferring, Zimmer Biomet Holdings, SEIKAGAKU CORPORATION, Flexion Therapeutics, Bioventus and Anika Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Joint Pain Injections market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Joint Pain Injections Market by Company
Chugai Pharmaceutical
Sanofi
Pfizer
Ferring
Zimmer Biomet Holdings
SEIKAGAKU CORPORATION
Flexion Therapeutics
Bioventus
Anika Therapeutics
Allergan
Joint Pain Injections Segment by Type
Corticosteroid Injections
Hyaluronic Acid Injections
Others
Joint Pain Injections Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Joint Pain Injections Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Joint Pain Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Joint Pain Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Joint Pain Injections.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Joint Pain Injections manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Joint Pain Injections by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Joint Pain Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Corticosteroid Injections
- Hyaluronic Acid Injections
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Chugai Pharmaceutical
- Sanofi
- Pfizer
- Ferring
- Zimmer Biomet Holdings
- SEIKAGAKU CORPORATION
- Flexion Therapeutics
- Bioventus
- Anika Therapeutics
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Joint Pain Injections Market Size (2021-2032)
- 2.2.2 Global Joint Pain Injections Sales (2021-2032)
- 2.2.3 Global Joint Pain Injections Market Average Price (2021-2032)
- 2.3 Joint Pain Injections by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Corticosteroid Injections
- 2.3.3 Hyaluronic Acid Injections
- 2.3.4 Others
- 2.4 Joint Pain Injections by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Joint Pain Injections Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Joint Pain Injections Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Joint Pain Injections Revenue of Manufacturers (2021-2026)
- 3.4 Global Joint Pain Injections Average Price by Manufacturers (2021-2026)
- 3.5 Global Joint Pain Injections Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Joint Pain Injections, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Joint Pain Injections, Product Type & Application
- 3.8 Global Manufacturers of Joint Pain Injections, Established Date
- 3.9 Global Joint Pain Injections Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chugai Pharmaceutical
- 4.1.1 Chugai Pharmaceutical Company Information
- 4.1.2 Chugai Pharmaceutical Business Overview
- 4.1.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chugai Pharmaceutical Joint Pain Injections Product Portfolio
- 4.1.5 Chugai Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Joint Pain Injections Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Joint Pain Injections Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Ferring
- 4.4.1 Ferring Company Information
- 4.4.2 Ferring Business Overview
- 4.4.3 Ferring Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ferring Joint Pain Injections Product Portfolio
- 4.4.5 Ferring Recent Developments
- 4.5 Zimmer Biomet Holdings
- 4.5.1 Zimmer Biomet Holdings Company Information
- 4.5.2 Zimmer Biomet Holdings Business Overview
- 4.5.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zimmer Biomet Holdings Joint Pain Injections Product Portfolio
- 4.5.5 Zimmer Biomet Holdings Recent Developments
- 4.6 SEIKAGAKU CORPORATION
- 4.6.1 SEIKAGAKU CORPORATION Company Information
- 4.6.2 SEIKAGAKU CORPORATION Business Overview
- 4.6.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio
- 4.6.5 SEIKAGAKU CORPORATION Recent Developments
- 4.7 Flexion Therapeutics
- 4.7.1 Flexion Therapeutics Company Information
- 4.7.2 Flexion Therapeutics Business Overview
- 4.7.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Flexion Therapeutics Joint Pain Injections Product Portfolio
- 4.7.5 Flexion Therapeutics Recent Developments
- 4.8 Bioventus
- 4.8.1 Bioventus Company Information
- 4.8.2 Bioventus Business Overview
- 4.8.3 Bioventus Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bioventus Joint Pain Injections Product Portfolio
- 4.8.5 Bioventus Recent Developments
- 4.9 Anika Therapeutics
- 4.9.1 Anika Therapeutics Company Information
- 4.9.2 Anika Therapeutics Business Overview
- 4.9.3 Anika Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Anika Therapeutics Joint Pain Injections Product Portfolio
- 4.9.5 Anika Therapeutics Recent Developments
- 4.10 Allergan
- 4.10.1 Allergan Company Information
- 4.10.2 Allergan Business Overview
- 4.10.3 Allergan Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Allergan Joint Pain Injections Product Portfolio
- 4.10.5 Allergan Recent Developments
5 Global Joint Pain Injections Market Scenario by Region
- 5.1 Global Joint Pain Injections Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Joint Pain Injections Sales by Region: 2021-2032
- 5.2.1 Global Joint Pain Injections Sales by Region: 2021-2026
- 5.2.2 Global Joint Pain Injections Sales by Region: 2027-2032
- 5.3 Global Joint Pain Injections Revenue by Region: 2021-2032
- 5.3.1 Global Joint Pain Injections Revenue by Region: 2021-2026
- 5.3.2 Global Joint Pain Injections Revenue by Region: 2027-2032
- 5.4 North America Joint Pain Injections Market Facts & Figures by Country
- 5.4.1 North America Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Joint Pain Injections Sales by Country (2021-2032)
- 5.4.3 North America Joint Pain Injections Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Joint Pain Injections Market Facts & Figures by Country
- 5.5.1 Europe Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Joint Pain Injections Sales by Country (2021-2032)
- 5.5.3 Europe Joint Pain Injections Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Joint Pain Injections Market Facts & Figures by Country
- 5.6.1 Asia Pacific Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Joint Pain Injections Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Joint Pain Injections Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Joint Pain Injections Market Facts & Figures by Country
- 5.7.1 South America Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Joint Pain Injections Sales by Country (2021-2032)
- 5.7.3 South America Joint Pain Injections Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Joint Pain Injections Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Joint Pain Injections Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Joint Pain Injections Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Joint Pain Injections Sales by Type (2021-2032)
- 6.1.1 Global Joint Pain Injections Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Joint Pain Injections Sales Market Share by Type (2021-2032)
- 6.2 Global Joint Pain Injections Revenue by Type (2021-2032)
- 6.2.1 Global Joint Pain Injections Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Joint Pain Injections Revenue Market Share by Type (2021-2032)
- 6.3 Global Joint Pain Injections Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Joint Pain Injections Sales by Application (2021-2032)
- 7.1.1 Global Joint Pain Injections Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Joint Pain Injections Sales Market Share by Application (2021-2032)
- 7.2 Global Joint Pain Injections Revenue by Application (2021-2032)
- 7.2.1 Global Joint Pain Injections Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Joint Pain Injections Revenue Market Share by Application (2021-2032)
- 7.3 Global Joint Pain Injections Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Joint Pain Injections Value Chain Analysis
- 8.1.1 Joint Pain Injections Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Joint Pain Injections Production Mode & Process
- 8.2 Joint Pain Injections Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Joint Pain Injections Distributors
- 8.2.3 Joint Pain Injections Customers
9 Global Joint Pain Injections Analyzing Market Dynamics
- 9.1 Joint Pain Injections Industry Trends
- 9.2 Joint Pain Injections Industry Drivers
- 9.3 Joint Pain Injections Industry Opportunities and Challenges
- 9.4 Joint Pain Injections Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst